Rheumatoid arthritis
RecruitingStudy Comparing Conventional Therapy and Biologic Treatments for Early Rheumatoid Arthritis Using Hydroxychloroquine, Abatacept, and Azathioprine in Responsive Patients
Study Comparing Conventional Therapy and Biologic Treatments for Early Rheumatoid Arthritis Using Hydroxychloroquine, Abatacept, and Azathioprine in Responsive Patients
- Disease:Rheumatoid arthritis
- Substances:AbataceptAzathioprine+8
Sweden- Participants:18–64 years · 65+ years
- Substances:Abatacept
- Sponsor:Karolinska Institutet












